Lisa A Carey

发表

The Use of Bayesian Hierarchical Models for Adaptive Randomization in Biomarker-Driven Phase II Studies

Joseph G Ibrahim, William T Barry, Charles M Perou, 2015, Journal of biopharmaceutical statistics.

Gene expression profiling in breast cancer

Lisa A Carey, L. Carey, S. Morris, 2007, Current opinion in oncology.

Estrogen-regulated genes predict survival in hormone receptor-positive breast cancers.

Zhiyuan Hu, Charles M Perou, Melissa A Troester, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Blood vessel morphologic changes depicted with MR angiography during treatment of brain metastases: a feasibility study.

Weili Lin, Donglin Zeng, Elizabeth Bullitt, 2007, Radiology.

Knowledge of genomic testing among early‐stage breast cancer patients

Noel T Brewer, Valesca P Retèl, Lisa A Carey, 2011, Psycho-oncology.

Building prognostic models for breast cancer patients using clinical variables and hundreds of gene expression signatures

Yufeng Liu, Charles M Perou, Joel S Parker, 2011, BMC Medical Genomics.

Breast carcinomas arising at a young age: unique biology or a surrogate for aggressive intrinsic subtypes?

Charles M Perou, Joel S Parker, Lisa A Carey, 2011, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Gene-expression analysis and the basal-like breast cancer subtype.

Lisa A Carey, L. Carey, Timothy J Finnegan, 2007, Future oncology.

EGFR associated expression profiles vary with breast tumor subtype

Charles M Perou, Melissa A Troester, Katherine A Hoadley, 2007, BMC Genomics.

Novel methylated biomarkers and a robust assay to detect circulating tumor DNA in metastatic breast cancer.

Zhe Zhang, Leslie Cope, Christopher Umbricht, 2014, Cancer research.

Directed therapy of subtypes of triple-negative breast cancer.

Lisa A Carey, L. Carey, 2010, The oncologist.

A compact VEGF signature associated with distant metastases and poor outcomes

Zhiyuan Hu, Charles M Perou, Olufunmilayo I Olopade, 2009, BMC medicine.

TBCRC 001: randomized phase II study of cetuximab in combination with carboplatin in stage IV triple-negative breast cancer.

Anastasia Ivanova, Charles M Perou, Katherine A Hoadley, 2012, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

Neoadjuvant clinical trial designs: Challenges of the genomic era.

Lisa A Carey, 2015, Breast.

Racial Differences in PAM50 Subtypes in the Carolina Breast Cancer Study

Zhiyuan Hu, Charles M Perou, Andrew F Olshan, 2018, Journal of the National Cancer Institute.

Gene expression in extratumoral microenvironment predicts clinical outcome in breast cancer patients

Melissa A Troester, Jason R. Pirone, Lisa A Carey, 2012, Breast Cancer Research.

A common variant at the TERT-CLPTM1L locus is associated with estrogen receptor–negative breast cancer

Jane E. Carpenter, Peter Kraft, Gary K. Chen, 2011, Nature Genetics.

Understanding and treating triple-negative breast cancer.

Lisa A Carey, L. Carey, C. Anders, 2008, Oncology.

Current Treatment Paradigms for the Management of Patients with Brain Metastases

Lisa A Carey, L. Carey, M. Ewend, 2005, Neurosurgery.

Estrogen and Progesterone Receptor Testing in Breast Cancer: American Society of Clinical Oncology/College of American Pathologists Guideline Update.

David L Rimm, Charles M Perou, Lisa M McShane, 2020, Archives of pathology & laboratory medicine.

Clinical trials in triple negative breast cancer.

Lisa A Carey, L. Carey, W. Sikov, 2010, Breast disease.